FDA Adverse Event Injury Summary report: N

CRYSTALENS

MDR report key: 770144 · Received October 17, 2006

Report

Report Number
2031924-2006-00029
Event Type
Injury
Date Received
October 17, 2006
Date of Event
August 28, 2006
Report Date
September 21, 2006
Manufacturer
EYEONICS, INC.
Product Code
HQL
PMA / PMN Number
P030002
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
ME, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE HISTORY RECORDS WERE REVIEWED AND THERE WERE NO DISCREPANCIES OR UNUSUAL FINDINGS. THE IOL REMAINS IMPLANTED IN THE PATIENT AND IS THEREFORE UNAVAILABLE FOR EVALUATION.

Description of Event or Problem · 1

THE PATIENT PRESENTED WITH DECREASED VISUAL ACUITY ONE MONTH AFTER CATARACT SURGERY WITH IMPLANTATION OF THE CRYSTALENS IN THE RIGHT EYE. THE PATIENT WAS DIAGNOSED WITH CYSTOID MACULAR EDEMA AND THE FLUORESCEIN ANGIOGRAPHY REVEALED SLIGHT MACULAR EDEMA EXTENDING FROM THE TOP OF A BRANCH VEIN OCCLUSION (LOCATED INFERIOR TO THE RIGHT MACULA). THE BVO WAS NOTED PREOPERATIVELY. THE PATIENT WAS TREATED WITH TOPICAL STEROID & NSAID GTTS AND INTRAVITREAL INJECTION OF KENALOG. THE PHYSICIAN BELIEVES THE CME IS SECONDARY TO THE BVO AND NOT TO THE CRYSTALENS, HOWEVER THE EVENT IS BEING REPORTED CONSERVATIVELY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CRYSTALENS INTRAOCULAR LENS HQL EYEONICS, INC. AT-45SE 003938

Patients

Seq Age Sex Outcome Treatment
1 UNKNOWN Required Intervention